Oct. 3 at 7:07 PM
$CDTX Pretty quiet day, all things considered. That said, we were sitting in the low 70s only a couple of weeks ago, so fair to assume some of the BARDA news was already priced in.
We're a long way away from the analysts' targets and from a valuation that fairly represents future cashflows, IMO.
We still haven't heard from the company about their breakthrough therapy designation and CNPV applications.. No idea when they might get the CNPV answer, but the BTD response should be in by now (if it wasn't affected by the shutdown). Maybe we get some news next week to keep the momentum going!
